Screener
Climb Bio, Inc. CLYM Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Climb Bio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210357
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total assets | $152,372 | $167,744 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $860 | $2,269 |
| Accrued expenses and other current liabilities | 2,948 | 4,459 |
| Operating lease liabilities | 263 | 256 |
| Total current liabilities | 4,071 | 6,984 |
| Operating lease liabilities, net of current portion | 216 | 285 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Climb Bio, Inc.'s accounts payable?
- Climb Bio, Inc. (CLYM) reported accounts payable of $860K in Q1 2026.
- How has Climb Bio, Inc.'s accounts payable changed year-over-year?
- Climb Bio, Inc.'s accounts payable increased by 10.7% year-over-year, from $777K to $860K.
- What is the long-term trend for Climb Bio, Inc.'s accounts payable?
- Over 4 years (2021 to 2025), Climb Bio, Inc.'s accounts payable has grown at a -10.1% compound annual growth rate (CAGR), from $6.86M to $4.47M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Climb Bio, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude